Distinct development of the glycinergic terminals in the ventral and dorsal horns of the mouse cervical spinal cord. 2017

Masanobu Sunagawa, and Chigusa Shimizu-Okabe, and Jeongtae Kim, and Shiori Kobayashi, and Yoshinori Kosaka, and Yuchio Yanagawa, and Masayuki Matsushita, and Akihito Okabe, and Chitoshi Takayama
Department of Molecular Anatomy, School of Medicine, University of the Ryukyus, 207 Uehara 207, Nishihara, Okinawa 9030215, Japan.

In the spinal cord, glycine and γ-amino butyric acid (GABA) are inhibitory neurotransmitters. However, the ontogeny of the glycinergic network remains unclear. To address this point, we examined the developmental formation of glycinergic terminals by immunohistochemistry for glycine transporter 2 (GlyT2), a marker of glycinergic terminals, in developing mouse cervical spinal cord. Furthermore, the developmental localization of GlyT2 was compared with that of glutamic acid decarboxylase (GAD), a marker of GABAergic terminals, and vesicular GABA transporter (VGAT), a marker of inhibitory terminals, by single and double immunolabeling. GlyT2-positive dots (glycinergic terminals) were first detected in the marginal zone on embryonic day 14 (E14). In the ventral horn, they were detected at E16 and increased in observed density during postnatal development. Until postnatal day 7 (P7), GAD-positive dots (GABAergic terminals) were dominant and GlyT2 immunolabeling was localized at GAD-positive dots. During the second postnatal week, GABAergic terminals markedly decreased and glycinergic terminals became dominant. In the dorsal horn, glycinergic terminals were detected at P0 in lamina IV and P7 in lamina III and developmentally increased. GlyT2 was also localized at GAD-positive dots, and colocalizing dots were dominant at P21. VGAT-positive dots (inhibitory terminals) continued to increase until P21. These results suggest that GABAergic terminals first appear during embryonic development and may often change to colocalizing terminals throughout the gray matter during development. The colocalizing terminals may remain in the dorsal horn, whereas in the ventral horn, colocalizing terminals may give rise to glycinergic terminals.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008297 Male Males
D008854 Microscopy, Electron Microscopy using an electron beam, instead of light, to visualize the sample, thereby allowing much greater magnification. The interactions of ELECTRONS with specimens are used to provide information about the fine structure of that specimen. In TRANSMISSION ELECTRON MICROSCOPY the reactions of the electrons that are transmitted through the specimen are imaged. In SCANNING ELECTRON MICROSCOPY an electron beam falls at a non-normal angle on the specimen and the image is derived from the reactions occurring above the plane of the specimen. Electron Microscopy
D005680 gamma-Aminobutyric Acid The most common inhibitory neurotransmitter in the central nervous system. 4-Aminobutyric Acid,GABA,4-Aminobutanoic Acid,Aminalon,Aminalone,Gammalon,Lithium GABA,gamma-Aminobutyric Acid, Calcium Salt (2:1),gamma-Aminobutyric Acid, Hydrochloride,gamma-Aminobutyric Acid, Monolithium Salt,gamma-Aminobutyric Acid, Monosodium Salt,gamma-Aminobutyric Acid, Zinc Salt (2:1),4 Aminobutanoic Acid,4 Aminobutyric Acid,Acid, Hydrochloride gamma-Aminobutyric,GABA, Lithium,Hydrochloride gamma-Aminobutyric Acid,gamma Aminobutyric Acid,gamma Aminobutyric Acid, Hydrochloride,gamma Aminobutyric Acid, Monolithium Salt,gamma Aminobutyric Acid, Monosodium Salt
D005998 Glycine A non-essential amino acid. It is found primarily in gelatin and silk fibroin and used therapeutically as a nutrient. It is also a fast inhibitory neurotransmitter. Aminoacetic Acid,Glycine, Monopotassium Salt,Glycine Carbonate (1:1), Monosodium Salt,Glycine Carbonate (2:1), Monolithium Salt,Glycine Carbonate (2:1), Monopotassium Salt,Glycine Carbonate (2:1), Monosodium Salt,Glycine Hydrochloride,Glycine Hydrochloride (2:1),Glycine Phosphate,Glycine Phosphate (1:1),Glycine Sulfate (3:1),Glycine, Calcium Salt,Glycine, Calcium Salt (2:1),Glycine, Cobalt Salt,Glycine, Copper Salt,Glycine, Monoammonium Salt,Glycine, Monosodium Salt,Glycine, Sodium Hydrogen Carbonate,Acid, Aminoacetic,Calcium Salt Glycine,Cobalt Salt Glycine,Copper Salt Glycine,Hydrochloride, Glycine,Monoammonium Salt Glycine,Monopotassium Salt Glycine,Monosodium Salt Glycine,Phosphate, Glycine,Salt Glycine, Monoammonium,Salt Glycine, Monopotassium,Salt Glycine, Monosodium
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000831 Animals, Newborn Refers to animals in the period of time just after birth. Animals, Neonatal,Animal, Neonatal,Animal, Newborn,Neonatal Animal,Neonatal Animals,Newborn Animal,Newborn Animals
D000870 Anterior Horn Cells MOTOR NEURONS in the anterior (ventral) horn of the SPINAL CORD which project to SKELETAL MUSCLES. Anterior Horn Neurons,Neurons, Anterior Horn,Neurons, Ventral Horn,Ventral Horn Cells,Ventral Horn Neurons,Anterior Horn Cell,Anterior Horn Neuron,Cell, Anterior Horn,Cell, Ventral Horn,Cells, Anterior Horn,Cells, Ventral Horn,Neuron, Anterior Horn,Neuron, Ventral Horn,Ventral Horn Cell,Ventral Horn Neuron
D013569 Synapses Specialized junctions at which a neuron communicates with a target cell. At classical synapses, a neuron's presynaptic terminal releases a chemical transmitter stored in synaptic vesicles which diffuses across a narrow synaptic cleft and activates receptors on the postsynaptic membrane of the target cell. The target may be a dendrite, cell body, or axon of another neuron, or a specialized region of a muscle or secretory cell. Neurons may also communicate via direct electrical coupling with ELECTRICAL SYNAPSES. Several other non-synaptic chemical or electric signal transmitting processes occur via extracellular mediated interactions. Synapse
D050487 Glycine Plasma Membrane Transport Proteins A family of sodium chloride-dependent neurotransmitter symporters that transport the amino acid GLYCINE. They differ from GLYCINE RECEPTORS, which signal cellular responses to GLYCINE. They are located primarily on the PLASMA MEMBRANE of NEURONS; GLIAL CELLS; EPITHELIAL CELLS; and RED BLOOD CELLS where they remove inhibitory neurotransmitter glycine from the EXTRACELLULAR SPACE. Neurotransmitter Transport Proteins, Glycine-Specific,Neurotransmitter Transporters, Glycine-Specific,GLYT Proteins,Glycine Plasma Membrane Transporter Proteins,Glycine Transporter,Glycine Transporter 1,Glycine Transporter 2,Glycine-Specific Neurotransmitter Transporters,Neurotransmitter Transport Proteins, Glycine Specific,Neurotransmitter Transporters, Glycine Specific,Transporters, Glycine-Specific Neurotransmitter

Related Publications

Masanobu Sunagawa, and Chigusa Shimizu-Okabe, and Jeongtae Kim, and Shiori Kobayashi, and Yoshinori Kosaka, and Yuchio Yanagawa, and Masayuki Matsushita, and Akihito Okabe, and Chitoshi Takayama
November 2012, Brain research,
Masanobu Sunagawa, and Chigusa Shimizu-Okabe, and Jeongtae Kim, and Shiori Kobayashi, and Yoshinori Kosaka, and Yuchio Yanagawa, and Masayuki Matsushita, and Akihito Okabe, and Chitoshi Takayama
January 1975, Folia morphologica,
Masanobu Sunagawa, and Chigusa Shimizu-Okabe, and Jeongtae Kim, and Shiori Kobayashi, and Yoshinori Kosaka, and Yuchio Yanagawa, and Masayuki Matsushita, and Akihito Okabe, and Chitoshi Takayama
August 2016, Viruses,
Masanobu Sunagawa, and Chigusa Shimizu-Okabe, and Jeongtae Kim, and Shiori Kobayashi, and Yoshinori Kosaka, and Yuchio Yanagawa, and Masayuki Matsushita, and Akihito Okabe, and Chitoshi Takayama
January 1975, Acta neuropathologica,
Masanobu Sunagawa, and Chigusa Shimizu-Okabe, and Jeongtae Kim, and Shiori Kobayashi, and Yoshinori Kosaka, and Yuchio Yanagawa, and Masayuki Matsushita, and Akihito Okabe, and Chitoshi Takayama
January 2005, Neuroscience,
Masanobu Sunagawa, and Chigusa Shimizu-Okabe, and Jeongtae Kim, and Shiori Kobayashi, and Yoshinori Kosaka, and Yuchio Yanagawa, and Masayuki Matsushita, and Akihito Okabe, and Chitoshi Takayama
April 2024, Neuron,
Masanobu Sunagawa, and Chigusa Shimizu-Okabe, and Jeongtae Kim, and Shiori Kobayashi, and Yoshinori Kosaka, and Yuchio Yanagawa, and Masayuki Matsushita, and Akihito Okabe, and Chitoshi Takayama
November 1997, Experimental neurology,
Masanobu Sunagawa, and Chigusa Shimizu-Okabe, and Jeongtae Kim, and Shiori Kobayashi, and Yoshinori Kosaka, and Yuchio Yanagawa, and Masayuki Matsushita, and Akihito Okabe, and Chitoshi Takayama
January 1988, Neurologia (Barcelona, Spain),
Masanobu Sunagawa, and Chigusa Shimizu-Okabe, and Jeongtae Kim, and Shiori Kobayashi, and Yoshinori Kosaka, and Yuchio Yanagawa, and Masayuki Matsushita, and Akihito Okabe, and Chitoshi Takayama
April 2016, Neuroscience research,
Masanobu Sunagawa, and Chigusa Shimizu-Okabe, and Jeongtae Kim, and Shiori Kobayashi, and Yoshinori Kosaka, and Yuchio Yanagawa, and Masayuki Matsushita, and Akihito Okabe, and Chitoshi Takayama
December 1977, Pain,
Copied contents to your clipboard!